Trials / Conditions / Malignant Neoplasms

Malignant Neoplasms

15 registered clinical trials studyying Malignant Neoplasms — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therap NCT07469683	Yonsei University	Phase 2
Recruiting	A Study of DEG6498 in Participants With Solid Tumors NCT07244835	Degron Therapeutics Co.	Phase 1
Recruiting	A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With A NCT05538130	Pfizer	Phase 1
Recruiting	A Multi Center Study of Sexual Toxicities After Radiotherapy NCT05394428	Icahn School of Medicine at Mount Sinai	—
Unknown	A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors NCT05315180	Betta Pharmaceuticals Co., Ltd.	Phase 1
Unknown	A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Met NCT04881981	Baptist Health, Louisville	Phase 1
Active Not Recruiting	CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors NCT04660929	Carisma Therapeutics Inc	Phase 1
Terminated	A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involveme NCT04543188	Pfizer	Phase 1
Unknown	A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors NCT04343859	Tianjin Chasesun Pharmaceutical Co., LTD	Phase 1
Unknown	The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients NCT04202848	The First Affiliated Hospital of Dalian Medical University	—
Unknown	Validation of the Italian Version of the PRO-CTCAE NCT04416672	National Cancer Institute, Naples	—
Terminated	Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Ste NCT01413386	Jong Taek, Lee	N/A
Completed	Community Cancer Centers Pilot Patient Survey NCT00786656	National Cancer Institute (NCI)	—
Completed	Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent NCT01512563	Taewoong Medical Co., Ltd.	N/A
Recruiting	Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease NCT00026884	National Cancer Institute (NCI)	—